Walgreens CFO’s 414,273 Shares Converted to $11.45 Cash and Divested Asset Right
Rhea-AI Filing Summary
Manmohan Mahajan, EVP and Global CFO of Walgreens Boots Alliance (WBA), reported a transaction dated 08/28/2025 disposing of 414,273 shares of WBA common stock, leaving him with 0 shares beneficially owned following the transaction. The Form 4 explains the disposition resulted from the Merger under the March 6, 2025 Merger Agreement, where each share was converted at the Effective Time into $11.45 in cash plus one Divested Asset Proceed Right. RSUs held by the reporting person were cancelled in exchange for the Per Share Consideration, although any unvested RSUs remain subject to the original vesting conditions tied to continued service.
Positive
- Per-share cash consideration of $11.45 was provided to the reporting person as part of the merger, ensuring cash realization for each converted share
- RSUs converted into Per Share Consideration, and unvested RSUs remain subject to original vesting, preserving compensation structure continuity
Negative
- Reporting person beneficial ownership reduced to 0 shares following the reported transaction
- Cancellation of RSUs means equity stake in the public company was eliminated at the Effective Time
Insights
TL;DR: Insider ownership reduced to zero due to merger consideration, with RSUs converted and unvested units still subject to service-based vesting.
The Form 4 documents a disposition of 414,273 shares by the EVP/CFO that is solely attributable to the corporate merger transaction. From a governance perspective, the disclosure is straightforward and consistent with merger mechanics: common stock and RSUs were converted into merger consideration rather than sold on the open market. The filing clarifies treatment of unvested RSUs, which preserves customary employment-based vesting obligations. This reduces public insider alignment but reflects deal terms rather than voluntary insider selling.
TL;DR: Disposition reflects merger consideration mechanics: per-share cash of $11.45 plus a divested-asset right; RSUs converted per the Merger Agreement.
The transaction arises from the Merger Agreement dated March 6, 2025, effective at the merger closing. Each common share converted into $11.45 cash and one Divested Asset Proceed Right, and RSUs were cancelled for the same Per Share Consideration with unvested units retaining service-based vesting. This filing documents the expected conversion of equity instruments under merger terms and explains post-closing treatment of equity awards for senior management.